趋化因子在肾细胞癌中的作用。
Role of chemokines in renal cell carcinoma.
作者信息
Parihar Jaspreet S, Tunuguntla Hari S G R
机构信息
Division of Urology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Hospital, New Brunswick, NJ.
出版信息
Rev Urol. 2014;16(3):118-21.
Abstract
With new frontiers of pharmaceutical therapies focusing on tumor growth and angiogenesis, understanding the interaction between immune system and tumor microenvironment has become ever more important. Chemokines and chemokine receptors appear to play an integral role in tumor characteristics. Evidence suggests CXCR4, CXCL5, CXCR7, and stromal derived factor-1 appear to be crucial in survival, growth, and metastasis of renal cell carcinoma. As the role of chemokines in renal cancer is becoming more evident, further research will lead to a better understanding of tumor biology and the development of new therapeutic targets to help improve survival.
摘要
随着药物治疗的新前沿聚焦于肿瘤生长和血管生成，了解免疫系统与肿瘤微环境之间的相互作用变得愈发重要。趋化因子和趋化因子受体似乎在肿瘤特征中发挥着不可或缺的作用。有证据表明，CXCR4、CXCL5、CXCR7和基质衍生因子-1在肾细胞癌的存活、生长和转移中似乎至关重要。随着趋化因子在肾癌中的作用变得越来越明显，进一步的研究将有助于更好地理解肿瘤生物学，并开发新的治疗靶点以提高生存率。
相似文献
1
Role of chemokines in renal cell carcinoma.趋化因子在肾细胞癌中的作用。
Rev Urol. 2014;16(3):118-21.
2
Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.CXCL12/CXCR4/CXCR7 轴在膀胱癌发病机制中的生物学/病理学功能。
Int J Clin Oncol. 2017 Dec;22(6):991-1000. doi: 10.1007/s10147-017-1187-x. Epub 2017 Oct 11.
3
Expression of chemokines and chemokine receptors in brain tumor tissue derived cells.趋化因子及趋化因子受体在脑肿瘤组织衍生细胞中的表达
Asian Pac J Cancer Prev. 2014;15(17):7201-5. doi: 10.7314/apjcp.2014.15.17.7201.
4
The role of CXC chemokines and their receptors in cancer.CXC趋化因子及其受体在癌症中的作用。
Cancer Lett. 2008 Aug 28;267(2):226-44. doi: 10.1016/j.canlet.2008.04.050. Epub 2008 Jun 24.
5
The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?CXCR4/SDF-1 趋化因子轴：骨转移的潜在治疗靶点？
Curr Pharm Des. 2010;16(11):1284-90. doi: 10.2174/138161210791034012.
6
Expression of C-X-C motif chemokine receptors 4 and 7 in salivary gland neoplasms.C-X-C 基序趋化因子受体 4 和 7 在唾液腺肿瘤中的表达。
Arch Oral Biol. 2017 Nov;83:136-144. doi: 10.1016/j.archoralbio.2017.07.012. Epub 2017 Jul 26.
7
The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review).CXCL12-CXCR4/CXCR7 轴在骨肉瘤进展和转移中的作用（综述）。
Int J Mol Med. 2013 Dec;32(6):1239-46. doi: 10.3892/ijmm.2013.1521. Epub 2013 Oct 11.
8
Chemokine receptor CXCR4: role in gastrointestinal cancer.趋化因子受体 CXCR4：在胃肠道癌中的作用。
Crit Rev Oncol Hematol. 2013 Dec;88(3):696-705. doi: 10.1016/j.critrevonc.2013.08.005. Epub 2013 Aug 28.
9
Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.雄激素受体与趋化因子受体4和7形成一个信号轴，以调节依赖于CXCL12的细胞运动。
BMC Cancer. 2015 Mar 31;15:204. doi: 10.1186/s12885-015-1201-5.
10
Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses.趋化因子在血管生成中的作用：CXCL12/SDF-1与CXCR4的相互作用，内皮细胞反应的关键调节因子。
Microcirculation. 2003 Jun;10(3-4):359-70. doi: 10.1038/sj.mn.7800200.
引用本文的文献
1
A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.一种用于局限性透明细胞肾细胞癌的基于预后微小RNA的特征：Bio-miR研究
Br J Cancer. 2025 May 7. doi: 10.1038/s41416-025-03008-2.
2
Cytokines in Renal Cell Carcinoma: A Step Towards Earlier Detection and Targeted Therapy.细胞因子在肾细胞癌中的作用：迈向早期检测和靶向治疗的一步。
Adv Exp Med Biol. 2022;1374:63-72. doi: 10.1007/5584_2021_700.
3
Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer.雄激素受体、剪接变体和松弛素2在肾癌中的差异表达
Life (Basel). 2021 Jul 22;11(8):731. doi: 10.3390/life11080731.
4
Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma.肾细胞癌的免疫治疗靶点与疗法
Immunotargets Ther. 2020 Nov 13;9:273-288. doi: 10.2147/ITT.S240889. eCollection 2020.
5
Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?肾癌中的血管生成与免疫：我们能否将一段不愉快的关系转变为美满的结合？
J Clin Med. 2020 Mar 28;9(4):930. doi: 10.3390/jcm9040930.
6
PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway.PBRM1通过趋化因子/趋化因子受体相互作用途径调节肾细胞癌的增殖和细胞周期。
PLoS One. 2017 Aug 28;12(8):e0180862. doi: 10.1371/journal.pone.0180862. eCollection 2017.
7
Different Cytokine and Chemokine Expression Patterns in Malignant Compared to Those in Nonmalignant Renal Cells.恶性肾细胞与非恶性肾细胞中细胞因子和趋化因子表达模式的差异。
Anal Cell Pathol (Amst). 2017;2017:7190546. doi: 10.1155/2017/7190546. Epub 2017 Jul 9.
8
MicroRNA-1 and MicroRNA-21 Individually Regulate Cellular Growth of Non-malignant and Malignant Renal Cells.微小RNA-1和微小RNA-21分别调控非恶性和恶性肾细胞的细胞生长。
In Vivo. 2017 Jul-Aug;31(4):625-630. doi: 10.21873/invivo.11103.
9
IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells.白细胞介素-6 参与肾癌细胞的恶性肿瘤形成和多柔比星敏感性。
Cell Adh Migr. 2018 Jan 2;12(1):28-36. doi: 10.1080/19336918.2017.1307482. Epub 2017 Jun 19.
10
Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma.新型肾癌干细胞标志物CXCR4的表达降低与高级别肾细胞癌相关。
J Cancer Res Clin Oncol. 2017 Jan;143(1):95-104. doi: 10.1007/s00432-016-2239-8. Epub 2016 Sep 16.
本文引用的文献
1
Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression.肿瘤细胞分泌的中性粒细胞趋化因子在肾细胞癌进展过程中引发肺部抗转移反应。
Oncogene. 2013 Apr 4;32(14):1752-60. doi: 10.1038/onc.2012.201. Epub 2012 Jun 4.
2
CXCR7: a novel tumor endothelial marker in renal cell carcinoma.CXCR7：肾细胞癌中的一种新型肿瘤内皮标志物。
Pathol Int. 2012 May;62(5):309-17. doi: 10.1111/j.1440-1827.2012.02792.x. Epub 2012 Feb 21.
3
Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis.趋化因子及其受体在肾肿瘤中的表达：组织学亚型的分子谱分析及其与转移的关系。
J Urol. 2012 Mar;187(3):827-33. doi: 10.1016/j.juro.2011.10.150. Epub 2012 Jan 15.
4
The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth.IL-8 调节的趋化因子受体 CXCR7 刺激 EGFR 信号通路促进前列腺癌生长。
Cancer Res. 2011 May 1;71(9):3268-77. doi: 10.1158/0008-5472.CAN-10-2769. Epub 2011 Mar 11.
5
Tumor-host interactions: a far-reaching relationship.肿瘤-宿主相互作用：一种深远的关系。
J Clin Oncol. 2010 Sep 10;28(26):4022-8. doi: 10.1200/JCO.2010.28.4257. Epub 2010 Jul 19.
6
Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer.同时表达 CXCR4 和 CXCR7 预示着肾癌预后不良。
Curr Cancer Drug Targets. 2010 Nov;10(7):772-81. doi: 10.2174/156800910793605839.
7
Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma.白细胞介素-8 介导肾细胞癌对血管生成抑制剂舒尼替尼的耐药性。
Cancer Res. 2010 Feb 1;70(3):1063-71. doi: 10.1158/0008-5472.CAN-09-3965. Epub 2010 Jan 26.
8
Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs.前列腺癌细胞中白细胞介素-8内在表达的缺失会导致细胞周期停滞、自发性凋亡，并提高化疗药物的疗效。
Mol Cancer. 2009 Jul 31;8:57. doi: 10.1186/1476-4598-8-57.
9
Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression.钙调神经磷酸酶抑制剂调节CXCR3剪接变体表达并介导肾癌进展。
J Am Soc Nephrol. 2008 Dec;19(12):2437-46. doi: 10.1681/ASN.2008040394. Epub 2008 Oct 2.
10
Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma.肾细胞癌分子靶向治疗的临床疗效及未来考量
Urol Oncol. 2008 Sep-Oct;26(5):543-9. doi: 10.1016/j.urolonc.2008.03.012.
Zotero 插件